SRx Health Solutions Inc. (SRXH)
 NYSEAMERICAN: SRXH · Real-Time Price · USD
 0.3523
 +0.0147 (4.35%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Company Description
SRx Health Solutions Inc. provides healthcare and medical treatment services.
It provides compounding services, pharmacy services, nursing healthcare, clinic services, vaccination services, caring for diabetes patients, travel health, compounding services, TB testing, and human immunodeficiency virus prevention services.
The company also operates retail-owned pharmacies. In addition, it provides COVID-19 testing services.
The company was founded in 2013 and is based in Toronto, Canada. It has additional locations in Canada and London, the United Kingdom.
SRx Health Solutions Inc.
 | Country | Canada | 
| Founded | 2013 | 
| Industry | Drug Manufacturers - General | 
| Sector | Healthcare | 
| Employees | 444 | 
| CEO | Kent Cunningham | 
Contact Details
| Address: 65 Queen St W , Unit 530 Toronto, ON M5H 2M5 Canada | |
| Phone | 844-577-9779 | 
| Website | srxhealth.ca | 
Stock Details
| Ticker Symbol | SRXH | 
| Exchange | NYSEAMERICAN | 
| Stock Type | Common Stock | 
| Fiscal Year | October - September | 
| Reporting Currency | CAD | 
| CIK Code | 0001711786 | 
| CUSIP Number | 08771Y402 | 
| ISIN Number | US08771Y4026 | 
| Employer ID | 82-1553794 | 
| SIC Code | 2834 | 
Key Executives
| Name | Position | 
|---|---|
| Kent Cunningham | Chief Executive Officer, President and Director | 
| Carolina Martinez | Chief Financial Officer | 
Latest SEC Filings
| Date | Type | Title | 
|---|---|---|
| Oct 17, 2025 | 8-K | Current Report | 
| Sep 12, 2025 | 8-K | Current Report | 
| Aug 22, 2025 | 8-K | Current Report | 
| Aug 12, 2025 | 10-Q | Quarterly Report | 
| Aug 5, 2025 | S-8 | Securities to be offered to employees in employee benefit plans | 
| Aug 5, 2025 | 8-K | Current Report | 
| Jun 24, 2025 | 8-K | Current Report | 
| Jun 20, 2025 | 8-K | Current Report | 
| Jun 16, 2025 | ARS | Filing | 
| Jun 16, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |